SPDR® S&P Biotech ETF (XBI)

217.89
Delayed Data
As of Feb 26
 +1.52 / +0.70%
Today’s Change
115.31
Today|||52-Week Range
219.11
+16.86%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+8.95% 3 years+40.95%
3 months+22.05% 5 years+31.50%
1 year+28.44% Since inception+18.06%
Data through 02/26/2015

Quote Details

Previous close$216.37
Open day’s range211.58 – 218.03
Net asset value (NAV)216.26 (02/25/2015)
Daily volume1,044,280
Average volume (3 months)670,238
Data as of 3:59pm ET, 02/26/2015

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+31.50%+22.29%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.171.47
Net assets$1.8B$1.6B
Average market cap$2.2B$35.3B
Average P/E--26.2
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
FMI Foundation Medicine Inc2.23%
HALO Halozyme Therapeutics Inc1.97%
NBIX Neurocrine Biosciences Inc1.68%
OPK OPKO Health Inc1.63%
ICPT Intercept Pharmaceuticals Inc1.61%
-- 1.61%
RARE Ultragenyx Pharmaceutical Inc1.54%
NVAX Novavax Inc1.49%
EXEL Exelixis Inc1.47%
ALKS Alkermes Plc1.46%

To view my watchlist

Not a member yet?

Sign up now for a free account